During the COVID-19 pandemic, pharmacy benefit managers, PBMs, have been taking real action to help patients. The pandemic has forced quick decision-making and adjustments, and PBMs have worked with members of the prescription drug and medical device supply and payment chain to get patients needed drugs, vaccinations, and tests. At…

Over the summer, when the U.S. Food and Drug Administration (FDA) approved the drug Aduhelm to treat Alzheimer’s Disease, I said that the news was met with both hope and skepticism, specifically in terms of safety, efficacy, and cost. Six months later, after careful analysis of the clinical trial and…

As we close out American Pharmacists Month in October, we are reminded of the enormous contributions that pharmacists across the country make each day to improve the health and well-being of Americans. …

Day in and day out, Americans are faced with challenges around prescription drug affordability and access. That issue is particularly problematic for many people living with diabetes. On average, insulin manufacturers nearly doubled their products’ prices in just five years. According to the U.S. Food and Drug Administration (FDA), “more…

One lesson from the COVID-19 pandemic is that the world relies on the biopharmaceutical industry to produce breakthroughs that improve health and vanquish disease. Unfortunately, these treatments sometimes come with exorbitant price tags. As policymakers consider the pandemic’s implications for the health care system, we are reminded that prescription drug…

The news this week that the Food and Drug Administration (FDA) approved Aduhelm to treat Alzheimer’s disease has been met with hope, but also skepticism in terms of the drug’s clinical safety and efficacy, and its cost. …

We stand at a promising moment in the course of the COVID-19 pandemic. Vaccines are becoming more widely available as states are opening vaccination appointments to broader categories of a greater number of individuals. …

On a new episode of The Pharmacy Benefit podcast, I was joined by April Alexander, General Counsel and Vice President of State Regulatory Affairs at PCMA, and Mark Newsom, the Principal and Founder of Health Evaluations. This conversation comes at a critical time as the Biden administration awaits confirmation…

For America’s pharmacy benefit managers, PBMs, the core mission is to increase access to affordable prescription drugs for all Americans. While PBMs have a proven track record of reducing prescription drug costs, it’s clear that for too many Americans prescription drugs are unaffordable — and that’s unacceptable. …